Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TRAIL-driven targeting and reversing cervical cancer radioresistance by seleno-nanotherapeutics through regulating cell metabolism
Wenxiao Jiang, Guanning Huang, Shuya Pan, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101033-101033
Closed Access | Times Cited: 11

Showing 11 citing articles:

Cell death pathways: molecular mechanisms and therapeutic targets for cancer
Shaohui Wang, Sa Guo, Jing Guo, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 11
Selenium Nanoparticles Enhance NK Cell‐Mediated Tumoricidal Activity in Malignant Pleural Effusion via the TrxR1‐IL‐18RAP‐pSTAT3 Pathway
Shaowei Liu, Naijian Li, Haoqiang Lai, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 30
Closed Access | Times Cited: 10
NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer
Min Yu, Mengdong Ni, Fei Xu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Peptide-based PET/CT imaging visualizes PD-L1-driven radioresistance in glioblastoma
Yong Wang, Zhiguo Liu, Yang Li, et al.
Drug Resistance Updates (2025) Vol. 79, pp. 101202-101202
Closed Access
TIAM2S Operates Multifaced Talents to Alleviate Radiosensitivity, Restrict Apoptosis, Provoke Cell Propagation, and Escalate Cell Migration for Aggravating Radioresistance-Intensified Cervical Cancer Progression
Pei-Chin Chuang, Wen-Hong Su, Ching‐Hua Hsieh, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 339-339
Open Access
The role of TRAF2 in pan-cancer revealed by integrating informatics and experimental validation
Xizheng Wang, Jianfeng Yuan, Chenchen Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
TRIAL-based combination therapies in cancers
Qiumin Deng, Luxuan Chen, Gui Zhang, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112570-112570
Closed Access | Times Cited: 3
The Role of TRAIL Signaling in Cancer: Searching for New Therapeutic Strategies
Cheng Luo, Shan He, Feng Shi, et al.
Biology (2024) Vol. 13, Iss. 7, pp. 521-521
Open Access | Times Cited: 3
Empowering radiotherapy: Harnessing nanomedicines to enhance radiation response and boost antitumor efficacy
Xiqian Zhuo, Reyida Aishajiang, Liang Yuan, et al.
Coordination Chemistry Reviews (2024) Vol. 520, pp. 216140-216140
Closed Access | Times Cited: 2
Metformin induces apoptosis in TRAIL-resistant colorectal cancer cells
Da Eun Lee, Hae Min Lee, Jun Ye, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024), pp. 119873-119873
Open Access | Times Cited: 1
Research progress on selenium system in cancer therapy: Focus on interface modifications and improvement of interactions
Hui He, Dingding Huang, Peng Xie, et al.
Surfaces and Interfaces (2024), pp. 105642-105642
Closed Access | Times Cited: 1
Mapping evolution and trends of cell membrane-coated nanoparticles: A bibliometric analysis and scoping review
Chong Li, Jing Hu, Jing He, et al.
Nanotechnology Reviews (2024) Vol. 13, Iss. 1
Open Access
Page 1

Scroll to top